Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 410,424 | 354,062 | 467,292 | 279,620 | 306,452 |
| Marketable Securities | 82,509 | 80,408 | 50,497 | 189,314 | 306,376 |
| Receivables | 614,282 | 534,699 | 504,870 | 495,852 | 241,942 |
| Inventories | 770,463 | 816,196 | 848,135 | 904,977 | 335,556 |
| TOTAL | $1,923,891 | $1,828,574 | $1,915,374 | $1,917,337 | $1,210,010 |
| Non-Current Assets | |||||
| PPE Net | 571,776 | 578,887 | 586,932 | 606,911 | 248,048 |
| Investments And Advances | 27,795 | 51,256 | 75,428 | 275,958 | 391,521 |
| Intangibles | 2,320,682 | 2,339,314 | 2,359,143 | 2,384,045 | 253,833 |
| Other Non-Current Assets | 149,649 | 145,581 | 149,206 | 171,624 | 109,053 |
| TOTAL | $3,069,902 | $3,115,038 | $3,170,709 | $3,438,538 | $1,002,455 |
| Total Assets | $4,993,793 | $4,943,612 | $5,086,083 | $5,355,875 | $2,212,465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 430,485 | 424,044 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 67,163 | 50,736 | 56,671 | 86,934 | 35,316 |
| Accrued Expenses | 215,885 | 210,011 | 240,460 | 221,670 | 89,606 |
| Other current liabilities | 38,221 | 29,649 | 61,035 | 54,339 | 13,595 |
| TOTAL | $794,146 | $786,324 | $392,347 | $428,722 | $155,220 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 417,400 | 409,723 | N/A |
| Deferred Revenues | 19,845 | 17,077 | 18,369 | 17,992 | 14,945 |
| Other Non-Current Liabilities | 196,018 | 194,975 | 193,956 | 197,954 | 66,881 |
| TOTAL | $223,282 | $234,927 | $695,777 | $739,868 | $72,180 |
| Total Liabilities | $1,017,428 | $1,021,251 | $1,088,124 | $1,168,590 | $227,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,407 | 135,057 | 135,372 | 137,793 | 100,461 |
| Common Shares | 135 | 135 | 136 | 140 | 100 |
| Retained earnings | 1,074,472 | 1,046,835 | 1,137,266 | 1,347,790 | 1,346,792 |
| Other shareholders' equity | -11,851 | -11,045 | -10,192 | -18,736 | -19,067 |
| TOTAL | $3,976,365 | $3,922,361 | $3,997,959 | $4,187,285 | $1,985,065 |
| Total Liabilities And Equity | $4,993,793 | $4,943,612 | $5,086,083 | $5,355,875 | $2,212,465 |